Numerous reports have shown that the expression levels of TH and DAT were reliable estimates of dopaminergic nerve terminal density in the striatum in both patients with PD [20, 21] and animal models [23, 24, 25]. This evidence concerns the gene SLC6A3 and Parkinson disease.